CUV 1.61% $14.68 clinuvel pharmaceuticals limited

Ann: Media release - First stroke patient with afamelanotide, page-20

  1. 2,000 Posts.
    lightbulb Created with Sketch. 311
    Phase 4 is post FDA approval collection of data.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.